A direct mechanistic link between growth control and a tumor cell immune function: increased interleukin-8 secretion accounts for elimination of Oct-1 antisense transformants from scid mice
Palubin, K.M.; Goodwin, B.L.; Niesen, M.I.; Le, E.A.; Osborne, A.R.; Blanck, G.
Anticancer Research 26(3a): 1733-1738
2006
ISSN/ISBN: 0250-7005 PMID: 16827100 Document Number: 603235
Background: Tumorigenesis involves the aberrant function of proteins that regulate growth control, including Oct-1. Oct-1 is a DNA binding transcription factor that activates genes that encode proteins required for S-phase and cell growth. For example, Oct-1 activates the histone H2B promoter and the promoters for the snRNPs. Oct-1 also represses certain promoters, including promoters of immune function genes, such as the IL-8 and the HL-4-DPA genes.Materials, Methods and Results: Oct-1 antisense transformants were determined to have reduced growth rates and other characteristics of growth control. Also, Oct-1 antisense transformants endured for a shorter time in scid mice,, being attributable to the increased expression of IL-8 by the Oct-1 antisense transformants.Conclusion: These results may help resolve the conundrum of why growth control de-regulation alone is not enough for tumorigenicity. The results also support the conclusion that the molecular mechanisms of growth control de-regulation and tumor cell immune functions are directly linked.